Profits from investments and other exceptional gains helped India's largest multinational drug company Glaxo Pharmaceuticals post a 157 per cent higher net profit at Rs 208.4 crore for the fourth quarter ended December 2008, compared with Rs 80.9 crore for the corresponding previous quarter in 2007.
Total income for the fourth quarter was at Rs 375.5 crore, 5.15 per cent higher than the Rs 357.1 crore for the fourth quarter in 2007, according to unaudited results for the quarter.
Consolidated net profit was up by 7.94 per cent at Rs 591 crore for the year ended December, 2008, where as the same was at Rs 547.5 crore for the previous year. GSK India generated a total income of Rs 1,742.6 crore for the year ended December 31, 2008, 5.31 per cent higher than the Rs 1,654.6 crore income for the year ended December 31, 2007.
